BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24144640)

  • 21. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
    Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
    Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.
    Vlachos A; Federman N; Reyes-Haley C; Abramson J; Lipton JM
    Bone Marrow Transplant; 2001 Feb; 27(4):381-6. PubMed ID: 11313667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative donor hematopoietic cell transplantation for Fanconi anemia.
    MacMillan ML; DeFor TE; Young JA; Dusenbery KE; Blazar BR; Slungaard A; Zierhut H; Weisdorf DJ; Wagner JE
    Blood; 2015 Jun; 125(24):3798-804. PubMed ID: 25824692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands.
    Smetsers SE; Smiers FJ; Bresters D; Sonnevelt MC; Bierings MB
    Br J Haematol; 2016 Sep; 174(6):952-61. PubMed ID: 27470218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
    Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Association of Pediatric Hematology-Oncology).
    Svahn J; Bagnasco F; Cappelli E; Onofrillo D; Caruso S; Corsolini F; De Rocco D; Savoia A; Longoni D; Pillon M; Marra N; Ramenghi U; Farruggia P; Locasciulli A; Addari C; Cerri C; Mastrodicasa E; Casazza G; Verzegnassi F; Riccardi F; Haupt R; Barone A; Cesaro S; Cugno C; Dufour C
    Am J Hematol; 2016 Jul; 91(7):666-71. PubMed ID: 27013026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Murillo-Sanjuán L; González-Vicent M; Argilés Aparicio B; Badell Serra I; Rodríguez Villa A; Uria Oficialdegui ML; López-Duarte M; Beléndez-Bieler C; Sastre Urgelles A; Sevilla Navarro J; Diaz-de-Heredia C;
    Bone Marrow Transplant; 2021 May; 56(5):1213-1216. PubMed ID: 33303901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.
    Ayas M; Siddiqui K; Al-Jefri A; El-Solh H; Al-Ahmari A; Khairy A; Markiz S; Shahin H; Al-Musa A; Al-Seraihy A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1599-603. PubMed ID: 24960628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
    Spitzer B; Jakubowski AA; Papadopoulos EB; Fuller K; Hilden PD; Young JW; Barker JN; Koehne G; Perales MA; Hsu KC; van den Brink MR; Kernan NA; Prockop SE; Scaradavou A; Castro-Malaspina H; O'Reilly RJ; Boulad F
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2088-2095. PubMed ID: 28711727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Mixed Chimerism After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients With Fanconi Anemia Impact on Outcome?
    Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Al-Anazi A; Khan S; El-Solh H; Al-Seraihi A
    Transplant Cell Ther; 2021 Mar; 27(3):257.e1-257.e6. PubMed ID: 33781527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution.
    de Medeiros CR; Bitencourt MA; Zanis-Neto J; Maluf EC; Carvalho DS; Bonfim CS; Funke VM; Setubal DC; Farah N; Pasquini R
    Braz J Med Biol Res; 2006 Oct; 39(10):1297-304. PubMed ID: 17053839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia.
    Chao MM; Ebell W; Bader P; Beier R; Burkhardt B; Feuchtinger T; Handgretinger R; Hanenberg H; Koehl U; Kratz C; Kremens B; Lang P; Meisel R; Mueller I; Roessig C; Sauer M; Schlegel PG; Schulz A; Strahm B; Thol F; Sykora KW
    Klin Padiatr; 2015 May; 227(3):157-65. PubMed ID: 25985449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fanconi anemia: a single center experience of a large cohort.
    Kesici S; Ünal Ş; Kuşkonmaz B; Aytaç S; Çetin M; Gümrük F
    Turk J Pediatr; 2019; 61(4):477-484. PubMed ID: 31990462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
    Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How I treat MDS and AML in Fanconi anemia.
    Peffault de Latour R; Soulier J
    Blood; 2016 Jun; 127(24):2971-9. PubMed ID: 27020090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay.
    Dufort G; Pisano S; Incoronato A; Castiglioni M; Carracedo M; Pagés C; Simon E; Zuccolo S; Barcelona R; Mezzano R; Tiscornia A; Lemos F; Morosini F; Schelotto M; Giordano H; Carreto E; Bengoechea M; Boggia B; Rodriguez I; Guerrero L; Dabezies A; Castillo L
    Bone Marrow Transplant; 2012 May; 47(5):663-8. PubMed ID: 21765479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
    Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Alanazi A; Jafri R; Ayas MF; Al-Seraihi A
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2217-2221. PubMed ID: 31306778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience.
    Farzin A; Davies SM; Smith FO; Filipovich A; Hansen M; Auerbach AD; Harris RE
    Br J Haematol; 2007 Feb; 136(4):633-40. PubMed ID: 17367413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.